NDR Medical

What NDR Medical does

NDR Medical Technology Pte. Ltd. is a Singapore-headquartered medical device company founded in 2015 that develops AI-empowered interventional robotic systems for minimally invasive percutaneous procedures. The company's product portfolio consists of two core platforms: ANT-C, which uses AI to analyze CT-scan images for automated lesion detection, needle path planning, and needle targeting; and ANT-X, which integrates C-arm fluoroscopy with AI software to enable safe and accurate real-time percutaneous needle placement. Both systems target procedures on the lungs, kidneys, pancreas, and spine, with reported clinical outcomes including 5-6 second needle puncture times, a learning curve of approximately 10 cases, and reduced radiation exposure to operating surgeons.

The company generates revenue through direct enterprise hardware sales of ANT-C and ANT-X systems to hospitals and medical centers, supplemented by regional distributor partnerships in markets such as India and South Korea. NDR has secured regulatory clearances across multiple jurisdictions — FDA 510(k) in June 2023, CE Mark in 2020, HSA Singapore and MDA Malaysia in Q1 2021 — with PMDA approval pursued in Japan. The company has built an APAC-centric operating footprint through a wholly-owned Japan subsidiary (established February 2022), a Malaysian branch, and a Chinese joint venture (Shanghai TargBot Medtech Limited), alongside research collaborations with Stanford University School of Medicine, Veterans Affairs Palo Alto Health Care System, and Nagoya City University. NDR is venture-backed, having closed an SGD $8 million Series A in July 2020 with Real Tech Holdings as a notable investor, and is led by co-founders Alan Goh (CEO) and Jason Ng (CTO), with a C-suite including a CFO (Carol Chen), CSO (Leong SH), and country-level Managing Director for Japan (Dr. Taguchi).

Name

NDR Medical

Legal name

NDR Medical Technology Pte. Ltd.

Website

https://ndrmedical.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

NDR Medical Technology is a Singapore-based medical device company that develops AI-empowered interventional robotic systems (ANT-C and ANT-X) for automated, image-guided percutaneous needle placement in hospitals performing minimally invasive procedures.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Interventional robotics
• Image-guided surgery
• Automated needle targeting
• Surgical robotics
• Percutaneous needle placement

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of AI-empowered interventional robotic systems (ANT-C and ANT-X) to hospitals and healthcare providers for use in minimally invasive surgical procedures.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

NDR Medical develops and sells AI-empowered interventional robotic systems — ANT-C and ANT-X — for minimally invasive percutaneous needle placement procedures. ANT-C uses AI to analyze CT-scan images for automated lesion detection, needle path planning, and targeting of lungs, kidneys, pancreas, and spine, while ANT-X integrates C-arm fluoroscopy with AI software for real-time percutaneous needle placement. The systems are sold to hospitals, healthcare providers, and academic medical institutions across Asia-Pacific, the US, and Europe under regulatory clearances including FDA 510(k), CE, HSA, and MDA.

Product overview

NDR Medical offers the ANT (Automated Needle Targeting) system, a suite of AI-empowered interventional robotics products consisting of ANT-C and ANT-X. ANT-C is a smart lesion targeting system that uses AI with CT-scan images for automated lesion detection, needle path planning, and needle targeting. ANT-X is an interventional robot that integrates C-arm fluoroscopy with AI software to enable safe and accurate percutaneous needle placement. Both products are designed to assist clinicians during image-guided procedures, reducing patient discomfort and improving outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• ANT-C: Smart lesion targeting system that uses AI on CT-scan images to automate lesion detection, needle path planning, and needle targeting with precision and accuracy.
• ANT-X

Products and services

• ANT-C (Automated Needle Targeting - CT) ANT-C is a smart lesion targeting system that uses AI to process CT-scan images for automated lesion detection, needle path planning, and needle targeting with high precision and accuracy. It is designed for image-guided percutaneous procedures targeting lungs, kidneys, pancreas, and spine, sold to hospitals and healthcare providers performing interventional radiology procedures.
• ANT-X (Automated Needle Targeting - X-ray) ANT-X is NDR Medical's first interventional robot integrating C-arm fluoroscopy with AI software to help clinicians achieve safe and accurate percutaneous needle placement. It enables real-time X-ray image acquisition and analysis for minimally invasive procedures, sold to hospitals and healthcare providers for use in interventional radiology and urology procedures.

Quantifiable outcome

• Needle puncture time reduced to 5-6 seconds by trained clinicians
• +2 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature2 records

Partnerships

Five partnerships are on record, tiered core, minor and flagship.

• Nagoya City UniversitycoreStrategic or Co-development Partner · 13 June 2022Clinical trial partnership with Nagoya City University Graduate School of Medical Sciences for automating renal access in kidney stone surgery using AI-enabled surgical robot.
• CGBIOcoreStrategic or Co-development Partner · 27 September 2021Partnership with CGBIO for introducing AI-empowered robotic intervention devices in South Korea with clinical trials planned at Korean medical institutions.
• Vishal Surgical EquipmentminorChannel Partner/ Reseller/ Distributor · 22 July 2021Partnership signed with Vishal Surgical Equipment in India for distribution and market presence of NDR Medical's interventional robotics products.
• Stanford University School of MedicineflagshipStrategic or Co-development Partner · 17 July 2021Strategic research collaboration with Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System for AI-empowered interventional robotics research and development.
• Veterans Affairs Palo Alto Health Care SystemflagshipStrategic or Co-development Partner · 17 July 2021Strategic research collaboration with Stanford University School of Medicine and VA Palo Alto Health Care System for advancing AI-empowered interventional robotics.

Scale indicators4 records

Recent moves9 records

Expansion highlights7 records

Broad incumbents

• Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics incumbent (da Vinci systems) with a massive installed base and clinical evidence library — a broad incumbent in the same surgical robotics category, though not specialized in NDR's percutaneous needle placement niche.
• Stryker: Stryker's MAKO robotic-arm assisted surgery platform and broader medical devices portfolio position it as a broad incumbent in surgical and interventional robotics, with established hospital relationships across multiple specialties.
• Siemens Healthineers: Siemens Healthineers provides image-guided therapy systems (including C-arm and CT-fluoroscopy platforms) used in percutaneous procedures alongside broader imaging hardware — a broad incumbent whose installed imaging base is directly adjacent to NDR's clinical workflow.
• Philips: Philips' Azurion image-guided therapy platform and interventional suite offerings target the same hospital interventional radiology and cardiology workflows as NDR — a broad incumbent in image-guided intervention with significant installed base advantage.
• Medtronic: Medtronic's Hugo robotic-assisted surgery system competes broadly in surgical robotics and the company also has deep hospital channel relationships across interventional procedures — a broad incumbent with overlapping but more general capabilities.

Direct peers

• Stereotaxis: Stereotaxis manufactures robotic systems for image-guided interventional procedures, primarily in electrophysiology and endovascular interventions — a directly comparable image-guided interventional robotics business serving similar hospital end-users.
• Robocath: Robocath develops the R-One robotic platform for coronary and vascular interventions — a directly comparable image-guided interventional robotics business serving the same hospital-based end-user profile as NDR.
• Quantum Surgical: Quantum Surgical's Epione robot assists with percutaneous tumor ablation procedures using CT-guided robotic needle placement — overlapping directly with NDR's ANT-C and ANT-X in percutaneous, image-guided robotic intervention workflows.
• XACT Robotics: XACT Robotics develops the XACT ACE Robotic System, an image-guided robotic insertion platform for percutaneous needle-based procedures — directly comparable to NDR's ANT system in both modality (CT/image-guided robotic needle placement) and clinical application.

Emerging players

• Perfint Healthcare: Perfint Healthcare offers robotic and image-guided solutions for CT-guided interventional procedures including ablation and biopsy, primarily in India and emerging APAC — comparable modality (CT image-guided robotic intervention) with similar workflow focus, though at a smaller scale than NDR.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC2a_2iUR6-iNCigW1ZrHDZw
• LinkedInlinkedin.com/company/ndr-medical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NDR Medical